EQUITY NOTICE: Rosen Law Firm Reminds Unilife Corporation Investors of Important Class Action Deadline - UNIS

NEW YORK, Nov. 27, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds all purchasers of the securities of Unilife Corporation UNIS from July 13, 2011 through September 9, 2013 (the "Class Period"), of the important December 31, 2013 lead plaintiff deadline in the class action.

To join the Unilife class action, go to the website at http://rosenlegal.com or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action. 

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, defendants issued materially false and misleading statements about Unilife's true business and financial condition in violation of the federal securities laws. Specifically, the complaint alleges that the defendants concealed from investors that: (i) the Company's Unifill syringes failed to comply with the U.S. Food and Drug Administration's ("FDA") validation process; (ii) Unilife's Quality Management System failed to comply with FDA regulations; (iii) Unilife intentionally increased its purchases of Unifill component parts to lead suppliers into believing that Unilife was producing at increased volumes even though it lacked customer demand or manufacturing capacity to support such purchases; and (iv) consequently, the Company's statements were materially false and misleading at all relevant times. When this adverse information was disclosed, it caused the price of Unilife stock to drop, damaging investors.

A class action lawsuit has already been filed on behalf of Unilife investors. If you wish to serve as lead plaintiff, you must move the Court no later than December 31, 2013. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm focuses on prosecuting securities class action litigation and actions involving financial fraud. The Rosen Law Firm represents investors throughout the globe concentrating its practice in securities class actions.